JP2024069192A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024069192A5 JP2024069192A5 JP2024015822A JP2024015822A JP2024069192A5 JP 2024069192 A5 JP2024069192 A5 JP 2024069192A5 JP 2024015822 A JP2024015822 A JP 2024015822A JP 2024015822 A JP2024015822 A JP 2024015822A JP 2024069192 A5 JP2024069192 A5 JP 2024069192A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- use according
- subject
- administration
- effective amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862677943P | 2018-05-30 | 2018-05-30 | |
| US62/677,943 | 2018-05-30 | ||
| US201862771398P | 2018-11-26 | 2018-11-26 | |
| US62/771,398 | 2018-11-26 | ||
| US201962822376P | 2019-03-22 | 2019-03-22 | |
| US62/822,376 | 2019-03-22 | ||
| GC2019-37663 | 2019-05-28 | ||
| GC201937663 | 2019-05-28 | ||
| PCT/US2019/034523 WO2019232130A1 (en) | 2018-05-30 | 2019-05-30 | Methods for increasing sepiapterin plasma exposure |
| JP2020566655A JP7502197B2 (ja) | 2018-05-30 | 2019-05-30 | セピアプテリン血漿曝露を増加させるための方法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020566655A Division JP7502197B2 (ja) | 2018-05-30 | 2019-05-30 | セピアプテリン血漿曝露を増加させるための方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024069192A JP2024069192A (ja) | 2024-05-21 |
| JP2024069192A5 true JP2024069192A5 (https=) | 2024-08-22 |
| JP7841005B2 JP7841005B2 (ja) | 2026-04-06 |
Family
ID=68699037
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020566655A Active JP7502197B2 (ja) | 2018-05-30 | 2019-05-30 | セピアプテリン血漿曝露を増加させるための方法 |
| JP2024015822A Active JP7841005B2 (ja) | 2018-05-30 | 2024-02-05 | セピアプテリン血漿曝露を増加させるための方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020566655A Active JP7502197B2 (ja) | 2018-05-30 | 2019-05-30 | セピアプテリン血漿曝露を増加させるための方法 |
Country Status (20)
| Country | Link |
|---|---|
| US (3) | US11617752B2 (https=) |
| EP (2) | EP3801536B1 (https=) |
| JP (2) | JP7502197B2 (https=) |
| CN (1) | CN112703002A (https=) |
| AU (2) | AU2019277382B2 (https=) |
| CA (1) | CA3102106A1 (https=) |
| DK (1) | DK3801536T3 (https=) |
| ES (1) | ES2986920T3 (https=) |
| FI (1) | FI3801536T3 (https=) |
| HR (1) | HRP20241213T1 (https=) |
| HU (1) | HUE068589T2 (https=) |
| LT (1) | LT3801536T (https=) |
| MD (1) | MD3801536T2 (https=) |
| MX (2) | MX2020012979A (https=) |
| PL (1) | PL3801536T3 (https=) |
| PT (1) | PT3801536T (https=) |
| RS (1) | RS65874B1 (https=) |
| SI (1) | SI3801536T1 (https=) |
| SM (1) | SMT202400430T1 (https=) |
| WO (1) | WO2019232130A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11072614B2 (en) | 2016-11-29 | 2021-07-27 | Ptc Therapeutics Mp, Inc. | Polymorphs of sepiapterin and salts thereof |
| US11130760B2 (en) | 2016-11-29 | 2021-09-28 | Ptc Therapeutics Mp, Inc. | Polymorphic form of sepiapterin |
| JP7811085B2 (ja) | 2017-09-01 | 2026-02-04 | ピーティーシー セラピューティクス エムピー，インコーポレイテッド | セピアプテリンを含む医薬組成物及びその使用 |
| EP3801536B1 (en) | 2018-05-30 | 2024-07-17 | PTC Therapeutics MP, Inc. | Administration of sepiapterin without food for use in a method for increasing sepiapterin plasma exposure |
| CN112654356A (zh) | 2018-05-30 | 2021-04-13 | Ptc医疗Mp公司 | 增加四氢生物蝶呤血浆暴露的组合物和方法 |
| CA3165636A1 (en) * | 2020-01-24 | 2021-07-29 | Neil Smith | Methods for treating parkinson's disease with sepiapterin |
| US20230077104A1 (en) * | 2020-02-19 | 2023-03-09 | The United States Government As Represented By The Department Of Veteran Affairs | L-sepiapterin and methods of use for treating diseases and disorders |
| JP2024506336A (ja) * | 2021-02-09 | 2024-02-13 | ピーティーシー セラピューティクス エムピー，インコーポレイテッド | 膠芽腫の治療方法 |
| EP4291196A1 (en) * | 2021-02-09 | 2023-12-20 | PTC Therapeutics MP, Inc. | Methods for treating covid-19 with sepiapterin |
| CN120732846A (zh) * | 2025-04-09 | 2025-10-03 | 中南大学湘雅医院 | 吲哚乙酸在制备预防或治疗高血压产品中的用途 |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5925323A (ja) * | 1982-03-03 | 1984-02-09 | 鐘淵化学工業株式会社 | プテリン誘導体からなる脳内神経伝達物質の関わる疾病の治療剤 |
| US5910304A (en) | 1982-12-13 | 1999-06-08 | Texas A&M University System | Low-dose oral administration of interferons |
| CA1320905C (en) | 1986-11-06 | 1993-08-03 | Joseph M. Cummins | Treatment of immuno-resistant disease |
| CA2228970A1 (en) | 1995-08-18 | 1997-02-27 | Donald W. Landry | Detection of organic compounds through regulation of antibody-catalyzed reactions |
| US6036949A (en) | 1998-03-05 | 2000-03-14 | Amarillo Biosciences, Inc. | Treatment of fibromyalgia with low doses of interferon |
| US8188043B2 (en) | 1999-07-28 | 2012-05-29 | The Board Of Trustees Of The Leland Stanford Jr. University | Nicotine in therapeutic angiogenesis and vasculogenesis |
| FR2859996B1 (fr) | 2003-09-19 | 2006-02-03 | Aventis Pharma Sa | Solvat acetonique du dimethoxy docetaxel et son procede de preparation |
| EP1696877A4 (en) * | 2003-11-13 | 2010-06-09 | Gen Hospital Corp | PROCESS FOR PAIN TREATMENT |
| US7732599B2 (en) | 2003-11-17 | 2010-06-08 | Biomarin Pharmaceutical Inc. | Process for preparing tetrahydrobiopterin and analogs of tetrahydrobiopterin |
| KR20070005550A (ko) | 2003-11-17 | 2007-01-10 | 바이오마린 파머수티컬 인크. | 대사 장애 치료를 위한 조성물 및 방법 |
| CA2678125C (en) | 2003-11-17 | 2014-10-14 | Merck Eprova Ag | Crystalline forms of (6r)-l-erythro-tetrahydrobiopterin dihydrochloride |
| WO2006055511A2 (en) | 2004-11-17 | 2006-05-26 | Biomarin Pharmaceutical Inc. | Stable tablet formulation of tetrahydrobiopterin |
| CA2588994A1 (en) | 2004-12-08 | 2006-06-15 | Biomarin Pharmaceutical Inc. | Methods and compositions for the treatment of pulmonary hypertension of the newborn |
| US7582799B2 (en) | 2005-04-28 | 2009-09-01 | Shiratori Pharmaceutical Co., Ltd. | Method for producing hydrazone derivatives |
| US20080075666A1 (en) | 2006-08-25 | 2008-03-27 | Dudley Samuel C Jr | Methods and compositions for treating diastolic dysfunction |
| WO2008128049A2 (en) | 2007-04-11 | 2008-10-23 | Biomarin Pharmaceutical Inc. | Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring |
| US20110144117A1 (en) | 2008-08-12 | 2011-06-16 | Orpha Swiss Gmbh | Pharmaceutical Dosage Form Containing Tetrahydrobiopterin |
| EP2562176B1 (en) | 2010-04-22 | 2018-08-15 | Nihon University | Medicinal agent and beverage/food for preventing cerebral dysfunction and improving same |
| US9884909B2 (en) | 2010-12-01 | 2018-02-06 | Alderbio Holdings Llc | Anti-NGF compositions and use thereof |
| CA2828685C (en) | 2011-03-01 | 2018-05-29 | Rubicon Research Private Limited | Stable compositions of tetrahydrobiopterin |
| US9216178B2 (en) | 2011-11-02 | 2015-12-22 | Biomarin Pharmaceutical Inc. | Dry blend formulation of tetrahydrobiopterin |
| IN2014DN09053A (https=) | 2012-05-07 | 2015-05-22 | Shiratori Pharm | |
| US10365267B2 (en) | 2014-10-31 | 2019-07-30 | Children's Medical Center Corporation | Methods and assays relating to sepiapterin reductase inhibition |
| US11130760B2 (en) | 2016-11-29 | 2021-09-28 | Ptc Therapeutics Mp, Inc. | Polymorphic form of sepiapterin |
| US11072614B2 (en) | 2016-11-29 | 2021-07-27 | Ptc Therapeutics Mp, Inc. | Polymorphs of sepiapterin and salts thereof |
| JP7811085B2 (ja) | 2017-09-01 | 2026-02-04 | ピーティーシー セラピューティクス エムピー，インコーポレイテッド | セピアプテリンを含む医薬組成物及びその使用 |
| KR102895167B1 (ko) * | 2017-11-23 | 2025-12-04 | 가부시키가이샤 한도오따이 에네루기 켄큐쇼 | 표시 장치 및 전자 기기 |
| AU2019277372B2 (en) | 2018-05-30 | 2024-12-19 | Ptc Therapeutics Mp, Inc. | Pharmaceutically acceptable salts of sepiapterin |
| CN112654356A (zh) * | 2018-05-30 | 2021-04-13 | Ptc医疗Mp公司 | 增加四氢生物蝶呤血浆暴露的组合物和方法 |
| EP3801536B1 (en) | 2018-05-30 | 2024-07-17 | PTC Therapeutics MP, Inc. | Administration of sepiapterin without food for use in a method for increasing sepiapterin plasma exposure |
| IL290321B1 (en) | 2019-08-05 | 2026-04-01 | Ptc Therapeutics Inc | Use of spiapterin and its metabolites for radiation exposure treatment |
| IL291565B1 (en) | 2019-09-25 | 2026-04-01 | Ptc Therapeutics Inc | Method for treating phenylalanine irregularity |
-
2019
- 2019-05-30 EP EP19811888.7A patent/EP3801536B1/en active Active
- 2019-05-30 SI SI201930841T patent/SI3801536T1/sl unknown
- 2019-05-30 JP JP2020566655A patent/JP7502197B2/ja active Active
- 2019-05-30 MD MDE20210340T patent/MD3801536T2/ro unknown
- 2019-05-30 RS RS20240943A patent/RS65874B1/sr unknown
- 2019-05-30 CA CA3102106A patent/CA3102106A1/en active Pending
- 2019-05-30 PL PL19811888.7T patent/PL3801536T3/pl unknown
- 2019-05-30 SM SM20240430T patent/SMT202400430T1/it unknown
- 2019-05-30 FI FIEP19811888.7T patent/FI3801536T3/fi active
- 2019-05-30 ES ES19811888T patent/ES2986920T3/es active Active
- 2019-05-30 AU AU2019277382A patent/AU2019277382B2/en active Active
- 2019-05-30 DK DK19811888.7T patent/DK3801536T3/da active
- 2019-05-30 LT LTEPPCT/US2019/034523T patent/LT3801536T/lt unknown
- 2019-05-30 HR HRP20241213TT patent/HRP20241213T1/hr unknown
- 2019-05-30 US US17/059,719 patent/US11617752B2/en active Active
- 2019-05-30 CN CN201980050839.7A patent/CN112703002A/zh active Pending
- 2019-05-30 WO PCT/US2019/034523 patent/WO2019232130A1/en not_active Ceased
- 2019-05-30 MX MX2020012979A patent/MX2020012979A/es unknown
- 2019-05-30 EP EP24187175.5A patent/EP4454704A3/en active Pending
- 2019-05-30 HU HUE19811888A patent/HUE068589T2/hu unknown
- 2019-05-30 PT PT198118887T patent/PT3801536T/pt unknown
-
2020
- 2020-11-30 MX MX2024005935A patent/MX2024005935A/es unknown
-
2023
- 2023-03-31 US US18/129,177 patent/US12329757B2/en active Active
-
2024
- 2024-02-05 JP JP2024015822A patent/JP7841005B2/ja active Active
-
2025
- 2025-02-06 AU AU2025200814A patent/AU2025200814A1/en active Pending
- 2025-05-13 US US19/206,193 patent/US20260091037A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024069192A5 (https=) | ||
| EP3426240B1 (en) | Mixed salt compositions for producing elevated and sustained ketosis | |
| JP2021525729A5 (https=) | ||
| JP2024074963A5 (https=) | ||
| JP2024063143A5 (https=) | ||
| JPS61277618A (ja) | 自閉症治療剤 | |
| JP2018507243A5 (https=) | ||
| FI3801536T3 (fi) | Sepiapteriinin antaminen ilman ruokaa käytettäväksi menetelmässä sepiapteriinin plasma-altistuksen lisäämiseksi | |
| CN103298464A (zh) | 复方组合物 | |
| JPS62111924A (ja) | 恐慌障害の軽減剤 | |
| JP2021525746A5 (https=) | ||
| FI4034122T3 (fi) | Menetelmiä hyperfenyylialaninemian hoitamiseksi | |
| JP2024019691A (ja) | 肺動脈性高血圧症および他疾患に関連する肺動脈性肺高血圧症の治療法 | |
| US20060233892A1 (en) | Topiramate compositions for treatment of headache | |
| MX2024006271A (es) | Nuevas combinaciones terapeuticas para el tratamiento de enfermedades pulmonares intersticiales fibrosantes progresivas. | |
| JPWO2019232130A5 (https=) | ||
| Oettmeier et al. | The procainebase-infusion: 20 years of experience of an alternative use with several therapeutical effects | |
| CN109172550B (zh) | 一种复合麻醉药物 | |
| JPWO2019232126A5 (https=) | ||
| Bardsley | Chronic respiratory failure in COPD: is there a place for a respiratory stimulant? | |
| JPWO2022026767A5 (https=) | ||
| RU2412701C2 (ru) | Способ снижения непереносимости противотуберкулезных препаратов | |
| JP2003159028A (ja) | 花粉症治療用食品 | |
| JPH0415766B2 (https=) | ||
| JP2004532866A (ja) | ２型インスリン抵抗性真性糖尿病患者の治療のためのビオチンと組合せてのアセチルｌ−カルニチンの使用 |